Journal of Ginseng Research · 2024 · 19 citations · 56 references
PharmacyBiotechnologyPharmaceutical BiotechnologyNatural Product BiosynthesisProtein EngineeringSynthetic BiologyMedicinal Plant ProductionMicrobial Natural Product BiosynthesisMicrobial Synthetic BiologyPlant Natural Product BiosynthesisPlant Synthetic BiologySynthetic Biology For MicrobesGinseng CultivationGlycoside Natural ProductsNeuroprotective AgentsNeuroprotective AntioxidantsPharmacological PotencyPlant-derived Natural ProductsProducer Cell Line Engineering
Synthetic biology approaches offer potential for large-scale and sustainable production of natural products with bioactive potency, including ginsenosides, providing a means to produce novel compounds with enhanced therapeutic properties. Ginseng, known for its non-toxic and potent qualities in traditional medicine, has been used for various medical needs. Ginseng has shown promise for its antioxidant and neuroprotective properties, and it has been used as a potential agent to boost immunity against various infections when used together with other drugs and vaccines. Given the increasing demand for ginsenosides and the challenges associated with traditional extraction methods, synthetic biology holds promise in the development of therapeutics. In this review, we discuss recent developments in microorganism producer engineering and ginsenoside production in microorganisms using synthetic biology approaches.
56
Production of the antimalarial drug precursor artemisinic acid in engineered yeast
Dae‐Kyun Ro, Eric M. Paradise, Mario Ouellet et al. · Nature · 2006 · 2.8K citations
High-level semi-synthetic production of the potent antimalarial artemisinin
Christopher J. Paddon, Patrick J. Westfall, Douglas J. Pitera et al. · Nature · 2013 · 2.1K citations · Full text